NFE2L2 and metabolic dysfunction-associated steatotic liver disease: While we noted that E2 played a protective role in reducing the enhanced levels of ROS and lipid accumulation associated with LPO-induced MASLD independently from genetic background (Fig. 8), we did not observe a clear involvement of NRF2 activation (Fig. S2).